Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Biochemical and Biophysical Research Communications|March 9, 2005
Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesisSaad Gad Kamel Mohamed, Eiji Sugiyama, Kouichiro Shinoda, et al.
Biological & Pharmaceutical Bulletin|January 5, 2010
Inhibition of tumor progression locus 2 protein kinase suppresses receptor activator of nuclear factor-kappaB ligand-induced osteoclastogenesis through down-regulation of the c-Fos and nuclear factor of activated T cells c1 genesKazuya Hirata, Hirofumi Taki, Kouichiro Shinoda, et al.
Case Reports in Rheumatology|December 20, 2023
A Case Report of Anti-TIF1-γAntibody-Positive Dermatomyositis Concomitant with Small Cell Neuroendocrine Carcinoma of the Urinary BladderHiroyuki Hounoki, Takafumi Onose, Miho Yamazaki, et al.
Modern Rheumatology|September 8, 2012
Recurrence of IgG4-related disease following treatment with rituximabJun Murakami, Shoko Matsui, Shin Ishizawa, et al.
Case Reports in Rheumatology|January 28, 2021
A Case of Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis Overlap SyndromeHiroyuki Hounoki, Koichiro Shinoda, Atsushi Matsui, et al.
Modern Rheumatology Case Reports|June 21, 2023
Thrombotic thrombocytopenic purpura that developed 3 years after systemic lupus erythematosus had remitted with rituximab therapyReina Tsuda, Toshiki Kido, Ikuma Okada, et al.
Modern Rheumatology Case Reports|June 21, 2023
An autopsy case of anti-MDA5 antibody-positive amyopathic dermatomyositis with an initial manifestation of panniculitis on the left upper armTakafumi Onose, Toshiki Kido, Ikuma Okada, et al.
Internal Medicine (Tokyo, Japan)|July 12, 2026
New-onset Systemic Lupus Erythematosus after Methimazole Exposure Followed by Autoantibody EmergenceAyaka Ishida, Ryoko Asano, Satoshi Yamaguchi, et al.
Modern Rheumatology Case Reports|February 5, 2026
Parallel improvement of chorea and antiphospholipid autoimmunity during combination therapy with hydroxychloroquine, belimumab and glucocorticoids in systemic lupus erythematosusRyoko Asano, Hiroki Maesaka, Satoshi Yamaguchi, et al.
Bone|July 14, 2007
Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cellsSaad Gad-Kamel Mohamed, Eiji Sugiyama, Kouichiro Shinoda, et al.
Pageof 3